Chester County News and Community Website
BALA CYNWYD, PA — Larimar Therapeutics (Nasdaq: LRMR) recently unveiled its Q1 2024 operational and financial results. The biopharmaceutical company is making remarkable progress in the clinical program of their …
Larimar Therapeutics’ Promising Q1 2024 Results Show Potential Treatment for Friedreich’s Ataxia Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a pioneering biopharmaceutical company, unveiled its first-quarter financial results for 2024, spotlighting not only solid fiscal performance but also significant strides in …
Context Therapeutics Posts Strong Q1 Financials, Advances Key Cancer Drug Trials Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced positive strides in its first-quarter progress, particularly in the development of firmonertinib, a promising drug for non-small cell lung …
ArriVent BioPharma Advances in Lung Cancer Research, Sets Sights on Future Milestones Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), a global manufacturer and supplier of semiconductors and passive components, disclosed its fiscal first quarter results, revealing a mix of challenges and …
Vishay Intertechnology Reports First Quarter Results, Eyes Recovery in H2 2024 Read More
KING OF PRUSSIA, PA — Vertex, Inc. (NASDAQ: VERX), a leading provider of tax technology solutions, reported a significant uptick in its first-quarter financial performance for 2024, highlighting strong revenue …
Vertex, Inc. Reports Robust First Quarter Growth, Fueled by Cloud Solutions Read More
MALVERN, PA — In a recent disclosure, Pennsylvania-based biotech firm Neuronetics (NASDAQ: STIM) announced its first-quarter financial performance for 2024, revealing a promising 12% increase in revenue compared to the …
Neuronetics Boasts 12% Revenue Increase, Expands Depression Treatment Sector Read More
CONSHOHOCKEN, PA — Following an exciting first quarter, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has reported great strides in both research and financial achievements. Among the most significant is the FDA …
Madrigal’s Pioneering NASH Treatment Receives FDA Approval, Raises $690 Million in Funding Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) recently shared its first quarter financial results. But even more newsworthy is the ongoing progress and future milestones slated for its novel …
Prelude Therapeutics Progresses in Cutting-Edge Cancer Treatment Development Read More
COLMAR, PA — Dorman Products, Inc. (NASDAQ: DORM), a leading supplier in the automotive aftermarket industry, reported a slight increase in net sales and a significant jump in profitability for …
Dorman Products Sees Profits Surge in First Quarter Amid Modest Sales Growth Read More
MALVERN, PA — Vishay Precision Group, Inc. (NYSE: VPG), a key player in precision measurement and sensing technologies, unveiled its first-quarter financial performance for fiscal year 2024, showing a revenue …
Vishay Precision Group Reports Dip in Revenue but Strong Margins in Q1 Fiscal 2024 Read More